[Pulmonary arteriovenous fistula in a newborn infant with hereditary telangiectasis]

Ugeskrift for Laeger
|April 17, 1989
PubMed

Insights

Hereditary hemorrhagic telangiectasia can cause pulmonary arteriovenous fistulas, even in newborns. Regular monitoring of children with this condition is crucial for early detection of vascular malformations.

Area of Science:

  • Vascular Medicine
  • Pediatric Cardiology
  • Genetics

Background:

  • Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder affecting blood vessels.
  • Pulmonary arteriovenous fistulas (PAVs) are abnormal connections between pulmonary arteries and veins.

Observation:

  • A case report details a newborn diagnosed with a pulmonary arteriovenous fistula.
  • The infant presented with hereditary hemorrhagic telangiectasia.

Findings:

  • Approximately 15% of HHT patients develop PAVs, often asymptomatic until adulthood.
  • Vascular malformations in HHT commonly manifest in the nasal mucosa, lungs, and gastrointestinal tract.

Implications:

  • Early and regular screening of children with HHT is essential.
  • Proactive monitoring can identify potential PAVs and other vascular abnormalities in at-risk pediatric populations.
  • Timely intervention may prevent complications associated with PAVs and other HHT-related vascular issues.